Does severe mucositis impair oncological outcome in head and neck cancer patients? A pooled analysis of two prospective studies with long-term follow-up
Abstract Background Oral mucositis (OM) is a frequently reported radiotherapy (RT)-induced acute toxicity in head and neck (H&N) cancer patients. Severe OM may be a dose-limiting condition, which can affect oncological outcomes. Therefore, we conducted a pooled analysis of two prospective studie...
Saved in:
| Main Authors: | Tanja Sprave, Jörg Sahlmann, Andreas R. Thomsen, Diana Klein, Henning Schäfer, Raluca Stoian, Vivek Verma, Anca-Ligia Grosu, Elsa Beatriz Monroy Ordonez |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-05-01
|
| Series: | BMC Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12885-025-14293-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluating the radiosensitivity of the oral microbiome to predict radiation-induced mucositis in head and neck cancer patients: A prospective trial
by: Andreas R. Thomsen, et al.
Published: (2025-03-01) -
Oral mucositis in patients with oncological pathology of the oropharyngeal region: review
by: A. O. Eremina, et al.
Published: (2020-11-01) -
Two cases of Mycoplasma pneumoniae-induced rash and mucositis
by: Flor Duarte, et al.
Published: (2025-01-01) -
Mucosal immunity and vaccination strategies: current insights and future perspectives
by: Zhihao Zhang, et al.
Published: (2025-08-01) -
Methotrexate and mucositis: A merry-go-round for oncologists
by: Kundan Mishra, et al.
Published: (2019-01-01)